Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for drug resistance, neoplasm (compound)
Most Correlated Studies
- Gastric carcinoma NCI-N87 cells showing sensitivity or resistance to trastuzumab
- Prostate cancer VCaP, LNCaP, & 22Rv1 cells resistant to pan BET bromodomain inhibitor ZEN-3694
- ER-positive breast cancer cells with acquired hormone-independence
- Prostate cancer VCaP cells resistant to testosterone, bicalutamide (BICA) and enzalutamide (ENZ)
- Gastric cancer GTL16 and lung cancer EBC-1 cells resistant to tyrosine kinase inhibitor crizotinib
Most Relevant Literature
- Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin.
- Multidrug resistance-associated proteins and their roles in multidrug resistance].
- Multidrug resistance-associated proteins are involved in the transport of the glutathione conjugates…
- Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible…
- Rapid determination of multidrug resistance-associated protein in cancer cells by capillary electrop…
Most Relevant Clinical Trials
- Olverembatinib for FGFR1-rearranged Neoplasms
- Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer…
- Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative Neoplasm
- Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multi…
- PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
